vs
Side-by-side financial comparison of FINANCIAL INSTITUTIONS INC (FISI) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
FINANCIAL INSTITUTIONS INC is the larger business by last-quarter revenue ($62.7M vs $47.7M, roughly 1.3× IRONWOOD PHARMACEUTICALS INC). FINANCIAL INSTITUTIONS INC runs the higher net margin — 33.5% vs -4.8%, a 38.3% gap on every dollar of revenue. Over the past eight quarters, FINANCIAL INSTITUTIONS INC's revenue compounded faster (-2.0% CAGR vs -20.2%).
The Mizuho Financial Group, Inc. , known from 2000 to 2003 as Mizuho Holdings and abbreviated as MHFG or simply Mizuho, is a Japanese banking holding company headquartered in the Ōtemachi district of Chiyoda, Tokyo, Japan. The group was formed in 2000–2002 by merger of Dai-Ichi Kangyo Bank, Fuji Bank, and Industrial Bank of Japan. The name mizuho (瑞穂) literally means "abundant rice" in Japanese and "harvest" in the figurative sense.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
FISI vs IRWD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.7M | $47.7M |
| Net Profit | $21.0M | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | — | 14.3% |
| Net Margin | 33.5% | -4.8% |
| Revenue YoY | — | -47.3% |
| Net Profit YoY | 24.3% | -200.9% |
| EPS (diluted) | $1.04 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $62.7M | — | ||
| Q4 25 | $64.1M | $47.7M | ||
| Q3 25 | $63.8M | $122.1M | ||
| Q2 25 | $59.7M | $85.2M | ||
| Q1 25 | $57.2M | $41.1M | ||
| Q4 24 | $41.6M | $90.5M | ||
| Q3 24 | $50.1M | $91.6M | ||
| Q2 24 | $65.2M | $94.4M |
| Q1 26 | $21.0M | — | ||
| Q4 25 | $20.0M | $-2.3M | ||
| Q3 25 | $20.5M | $40.1M | ||
| Q2 25 | $17.5M | $23.6M | ||
| Q1 25 | $16.9M | $-37.4M | ||
| Q4 24 | $-82.8M | $2.3M | ||
| Q3 24 | $13.5M | $3.6M | ||
| Q2 24 | $25.6M | $-860.0K |
| Q1 26 | — | — | ||
| Q4 25 | 37.4% | 14.3% | ||
| Q3 25 | 39.5% | 61.8% | ||
| Q2 25 | 36.0% | 53.2% | ||
| Q1 25 | 36.0% | -70.7% | ||
| Q4 24 | -276.9% | 34.8% | ||
| Q3 24 | 29.0% | 28.0% | ||
| Q2 24 | 46.2% | 26.5% |
| Q1 26 | 33.5% | — | ||
| Q4 25 | 38.3% | -4.8% | ||
| Q3 25 | 32.1% | 32.8% | ||
| Q2 25 | 29.3% | 27.7% | ||
| Q1 25 | 29.5% | -90.9% | ||
| Q4 24 | -198.9% | 2.5% | ||
| Q3 24 | 26.9% | 4.0% | ||
| Q2 24 | 39.3% | -0.9% |
| Q1 26 | $1.04 | — | ||
| Q4 25 | $0.96 | $0.01 | ||
| Q3 25 | $0.99 | $0.23 | ||
| Q2 25 | $0.85 | $0.14 | ||
| Q1 25 | $0.81 | $-0.23 | ||
| Q4 24 | $-5.32 | $0.03 | ||
| Q3 24 | $0.84 | $0.02 | ||
| Q2 24 | $1.62 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $85.5M | $215.5M |
| Total DebtLower is stronger | $114.0M | — |
| Stockholders' EquityBook value | — | $-261.8M |
| Total Assets | $6.3B | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $85.5M | — | ||
| Q4 25 | $108.8M | $215.5M | ||
| Q3 25 | $185.9M | $140.4M | ||
| Q2 25 | $93.0M | $92.9M | ||
| Q1 25 | $167.4M | $108.5M | ||
| Q4 24 | $87.3M | $88.6M | ||
| Q3 24 | — | $88.2M | ||
| Q2 24 | — | $105.5M |
| Q1 26 | $114.0M | — | ||
| Q4 25 | $193.7M | — | ||
| Q3 25 | $115.0M | $199.5M | ||
| Q2 25 | $115.0M | $199.3M | ||
| Q1 25 | $124.9M | $199.2M | ||
| Q4 24 | $124.8M | $199.0M | ||
| Q3 24 | $124.8M | $198.8M | ||
| Q2 24 | $124.7M | $198.6M |
| Q1 26 | — | — | ||
| Q4 25 | $628.9M | $-261.8M | ||
| Q3 25 | $621.7M | $-264.2M | ||
| Q2 25 | $601.7M | $-308.2M | ||
| Q1 25 | $589.9M | $-334.1M | ||
| Q4 24 | $569.0M | $-301.3M | ||
| Q3 24 | $500.3M | $-311.3M | ||
| Q2 24 | $467.7M | $-321.7M |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $396.9M | ||
| Q3 25 | $6.3B | $396.1M | ||
| Q2 25 | $6.1B | $342.9M | ||
| Q1 25 | $6.3B | $327.2M | ||
| Q4 24 | $6.1B | $350.9M | ||
| Q3 24 | $6.2B | $389.5M | ||
| Q2 24 | $6.1B | $395.6M |
| Q1 26 | — | — | ||
| Q4 25 | 0.31× | — | ||
| Q3 25 | 0.18× | — | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | 0.21× | — | ||
| Q4 24 | 0.22× | — | ||
| Q3 24 | 0.25× | — | ||
| Q2 24 | 0.27× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $74.6M |
| Free Cash FlowOCF − Capex | — | $74.6M |
| FCF MarginFCF / Revenue | — | 156.3% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $18.8M | $74.6M | ||
| Q3 25 | $-6.9M | $47.6M | ||
| Q2 25 | $-5.7M | $-15.1M | ||
| Q1 25 | $10.0M | $20.0M | ||
| Q4 24 | $77.1M | $15.2M | ||
| Q3 24 | $2.1M | $9.9M | ||
| Q2 24 | $35.7M | $33.5M |
| Q1 26 | — | — | ||
| Q4 25 | $13.3M | $74.6M | ||
| Q3 25 | $-7.9M | $47.6M | ||
| Q2 25 | $-7.3M | $-15.1M | ||
| Q1 25 | $9.2M | $19.9M | ||
| Q4 24 | $72.2M | — | ||
| Q3 24 | $-299.0K | $9.9M | ||
| Q2 24 | $34.7M | $33.4M |
| Q1 26 | — | — | ||
| Q4 25 | 20.7% | 156.3% | ||
| Q3 25 | -12.4% | 39.0% | ||
| Q2 25 | -12.3% | -17.7% | ||
| Q1 25 | 16.1% | 48.4% | ||
| Q4 24 | 173.3% | — | ||
| Q3 24 | -0.6% | 10.8% | ||
| Q2 24 | 53.3% | 35.4% |
| Q1 26 | — | — | ||
| Q4 25 | 8.7% | 0.0% | ||
| Q3 25 | 1.6% | 0.0% | ||
| Q2 25 | 2.7% | 0.0% | ||
| Q1 25 | 1.4% | 0.1% | ||
| Q4 24 | 11.9% | 0.0% | ||
| Q3 24 | 4.9% | 0.0% | ||
| Q2 24 | 1.5% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | 0.94× | — | ||
| Q3 25 | -0.34× | 1.19× | ||
| Q2 25 | -0.33× | -0.64× | ||
| Q1 25 | 0.59× | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | 0.16× | 2.71× | ||
| Q2 24 | 1.39× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FISI
| Net Interest Income | $52.0M | 83% |
| Noninterest Income | $10.7M | 17% |
IRWD
Segment breakdown not available.
